Form 4 for BLFS BIOLIFE SOLUTIONS INC
Accepted 2021-07-08 00:00:00 ET · period of report 2021-07-06 · accession 0001437749-21-016690 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2021-07-08 | 2021-07-06+ | BLFS | Rice Michael | CEO, Dir | M - OptEx | $1.64 | +22.9K | 280.8K | +9% | +$37.6K |
| DM | 2021-07-08 | 2021-07-06+ | BLFS | Rice Michael | CEO, Dir | S - Sale+OE | $46.21 | -22.9K | 269.3K | -8% | -$1.06M |
| DM | 2021-07-08 | 2021-07-06+ | BLFS | Rice Michael | CEO, Dir | M - OptEx | $0.00 | -22.9K | 126.1K | -15% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-07-06 | M | A | 11,461 | $1.64 | 280,771 | D | — | — | |
| 2 | Common | Common Stock | 2021-07-06 | S | D | 11,461 | $46.28 | 269,310 | D | — | — | (F2) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.22 to $46.80, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. |
| 3 | Common | Common Stock | 2021-07-08 | M | A | 11,464 | $1.64 | 280,774 | D | — | — | |
| 4 | Common | Common Stock | 2021-07-08 | S | D | 11,464 | $46.15 | 269,310 | D | — | — | (F3) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.15 to $47.93, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. |
| 5 | Derivative | Employee Stock Option | 2021-07-08 | M | D | 11,464 | $0.00 | 114,613 | D | $1.64 · — to 2021-12-20 | 11,464 Common Stock | (F4) The option vested in two equal annual installments based on the registrant's satisfaction of certain performance criteria for the fiscal year ending December 2017. The performance criteria for 2017 were met, resulting in vesting of the option as follows: 114,613 shares vested on March 8, 2018 and 114,613 shares vested on March 8, 2019. |
| 6 | Derivative | Employee Stock Option | 2021-07-06 | M | D | 11,461 | $0.00 | 126,077 | D | $1.64 · — to 2021-12-20 | 11,461 Common Stock | (F4) The option vested in two equal annual installments based on the registrant's satisfaction of certain performance criteria for the fiscal year ending December 2017. The performance criteria for 2017 were met, resulting in vesting of the option as follows: 114,613 shares vested on March 8, 2018 and 114,613 shares vested on March 8, 2019. |